Atlas Trials

Study to Evaluate the Clinical Efficacy and Safety of Tamsulosin Alone or in Combination With Solifenacin for the Treatment in Men With Lower Urinary Tract Symptoms Including Overactive Bladder Symptoms

Clinical trial NCT02715024 · COMPLETED

Trial details

NCT number
NCT02715024
Sponsor
Astellas Pharma Taiwan, Inc.
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Lower Urinary Tract SymptomsOveractive BladderBenign Prostatic Hyperplasia (BPH)
Start date
2007-09-01
Primary completion
2011-04-01
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.